Antonio Antón-Torres

5PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 23, 2024
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle

|Jul 25, 2023
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.

Javier Pascual, Miguel Gil-Gil, Paula Proszek

|Feb 07, 2023
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer.

Ángel Guerrero-Zotano, Stefania Belli, Christoph Zielinski

|Oct 14, 2022
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.

Virginia Lope, Angel Guerrero-Zotano, Emma Ruiz-Moreno

|Jul 24, 2021
Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer.

José Manuel López-Vega, Isabel Álvarez, Antonio Antón

Pageof 1

Frequent Collaborators

3 joint publications

Eva Maria Ciruelos Gil

3 joint publications

Begoña Bermejo

2 joint publications

Jesús Herranz

2 joint publications

Javier Pascual